“Conclusion: Combination treatment with apigenin and gemcitabine inhibited pancreatic cancer cell growth via cell cycle arrest, down-regulation of the prosurvival factor pAkt, and induction of apoptosis.”
“Results: Apigenin in combination with gemcitabine inhibited pancreatic cancer cell proliferation more than either agent alone.”